Norman Sharpless serves as Executive at G1 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Norman Sharpless has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 18, 2024 involved selling 20,000 shares valued at $0.
Norman Sharpless currently holds 20,000 shares of G1 Therapeutics, Inc. (GTHX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Norman Sharpless has been a net neutral trader of GTHX stock. They have purchased $0 and sold $0 worth of shares.
Norman Sharpless's most recent insider trade was on Sep 18, 2024, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 15, 2023 | GTHX | $0 | Award | 10,000 | $N/A | Discretionary |